Tag: Comt inhibitor

In the United States, nearly 90,000 people are diagnosed with Parkinson's disease each year [1.10]. For many, a key question becomes **what is Comtan prescribed for?** This medication serves as an adjunctive therapy to manage symptoms as the disease progresses.

In the United States, nearly 90,000 people are diagnosed with Parkinson's disease each year [1.6.2]. For many, managing symptoms involves understanding adjunct therapies. So, **what class of drug is Comtan?** It is a catechol-O-methyltransferase (COMT) inhibitor [1.2.4].

Patients with Parkinson's disease (PD) who have been on long-term levodopa therapy often face motor fluctuations and disabling "off" episodes as the medication's effect wears off. For these individuals, understanding what are the benefits of taking opicapone becomes crucial for optimizing treatment and improving their quality of life. Opicapone is a third-generation catechol-O-methyltransferase (COMT) inhibitor, which plays a key role in extending the availability of levodopa in the brain.

Approximately 2-3% of the population aged 65 or older are affected by Parkinson's disease, a condition often managed using therapies that include a COMT inhibitor. This class of drugs is a crucial tool in the pharmacological management of Parkinson's, specifically for addressing the 'wearing-off' periods that many patients experience.